Learn More
Medchemexpress LLC Fidrisertib | 2141955-96-4 | 98.2% | 562.70 g/mol | C31H42N6O4 | 10 MG

Supplier: Medchemexpress LLC HY11788710MG
Fidrisertib is an orally active small-molecule inhibitor of activin receptor-like kinase 2 (ALK2) used as a research reagent to study ALK/TGF-β signaling and related disease models. The compound is provided as a solid research chemical with indicated purity suitable for in vitro and preclinical research applications.
- Orally active ALK2 inhibitor, useful for studies of ALK/TGF-β pathways.
- Supplied as a solid research reagent with high reported purity.
- Relevant for oncology and fibrodysplasia ossificans progressiva research models.
- Soluble in common organic solvents such as DMSO for assay preparation.
- Provided in small research pack suitable for assay development and preclinical experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.